Beware of Dangerous Prescription Drugs
"Modern medicine has done wonderful things to improve the quality of our lives. Yet horrible suffering results, when defective products or medications cause unintended consequences,” states Long Island attorney, Rudolph Migliore.
The Commack, NY law firm of Rudolph F. X. Migliore, P.C. has recently begun taking cases related to two dangerous prescription medications, Reglan and Fosamax.
Reglan (metoclopramide) - is a prescription drug that came on the market in generic form in 1982 and is also sold in the U.S. under generic names such as, Pylomid, Primperan, Gastrosil, Maxeran, Metlazel, Dibertil, Maxolon, Metoclopramide, Primperan, Plasil and other names. Doctors prescribe the drug to treat a variety of gastro-intestinal maladies, from acid reflux, nausea and vomiting due to surgery and cancer chemotherapy to gastroparesis.
Despite the many studies showing that Reglan was associated with a neurological disorder, tardive dyskinesia, the drug's manufacturers did not warn of it on the label until 2004 and did not add the Black Box warning until February 2009.
Tardive dyskinesia causes uncontrollable, repetitive movements of the body, such as grimacing, lip smacking, eye blinking or rapid leg and arm movements. The symptoms are rarely reversible and there is no known treatment.
Further investigation into Reglan has determined that patients, including infants and children, and the elderly, face significant risk of developing tardive dyskinesia. The risk is especially associated with those who have been on the drug for a long time, sometimes after a few dosages and even after the patient stopped taking the drug.
Fosamax – is used to treat and prevent osteoporosis in post-menopausal women, steroid-induced osteoporosis in men and other bone diseases. Investigation into Fosamax-related femur fractures determined that women and men who took the bisphosphonate drug face significant risk of a spontaneous femur fracture injury. These atypical hip/thigh fractures occur in minor or "low impact" falls from a standing height or less, as opposed to a traumatic accident or injury.
The FDA and other independent research studies indicate that femur fracture patients have reported experiencing severe pain of the joints, muscles and/or bones for periods of weeks to months before a complete fracture occurred.
Legal Help for Individuals Harmed by Defective Prescription Drugs
Extensive product liability experience gives the Long Island law firm of Rudolph F.X. Migliore, P. C. the expertise to handle complex defective prescription drug cases. The Migliore firm has represented clients in wide range of product liability cases in the last three decades and has worked with nationally recognized co-counsel to reach successful settlements for clients.
If you or someone you care about has developed Reglan-induced tardive dyskinesia or who used the osteoporosis medication Fosamax and later suffered a femur (hip/thigh) fracture.
contact the Long Island, NY law firm of Rudolph F.X. Migliore, P.C. at (631) 543-3663 to arrange a free case evaluation. Visit: www.migliorelaw.com/
About Rudolph F.X. Migliore, P.C.
We are a civil and criminal law firm located on Long Island and offer legal services for victims of serious personal injury, including defective products, mesothelioma and medical malpractice. The firm’s practice extends to criminal defense, elder law and estate planning.
Showing posts with label Reglan. Show all posts
Showing posts with label Reglan. Show all posts
December 11, 2010
December 7, 2010
Legal Help for Victims of Reglan-Induced Tardive Dyskinesia
Do a quick web search and you’ll find online forums where victims of tardive dyskinesia share heart-wrenching stories about how the prescription drug Reglan harmed them.
Available in generic form since 1982, Reglan is also sold in the U.S. under the brand name Maxolon and other names. Despite the many studies showing that Reglan was associated with tardive dyskinesia, the drug's manufacturers did place a warning on the label until 2004, and did not add the Black Box warning until February 2009.
Further investigation into Reglan determined that patients, including infants and children, and the elderly, faced significant risk of developing tardive dyskinesia. The risk is especially associated with those who have been on the drug for a long time, although symptoms have surfaced in patients after short-term use. Even after patients stop taking Reglan, symptoms of tardive dyskinesia occur.
For more than 30 years, doctors have been prescribing the drug Reglan to treat acid reflux, nausea, vomiting (in cancer patients) and gastroparesis, leaving countless victims to suffer from the frightening effects of tardive dykinesia.
A neurological disorder, tardive dyskinesia causes uncontrollable, repetitive movements of the body, such as grimacing, lip smacking, eye blinking or rapid leg and arm movements. The symptoms are rarely reversible and there is no known treatment.
If you or someone you care about has taken Reglan and developed symptoms of tardive dyskinesia, legal help is available. Call the Long Island, NY law firm of Rudolph F.X. Migliore, P.C. at (631) 543-3663 for a no cost, no obligation case evaluation.
While the harm the drug caused cannot be undone, attorney Rudolph Migliore and his team will fight to recover compensation for damages and hold liable parties responsible.
Extensive product liability experience gives the Long Island law firm of Rudolph F.X. Migliore, P. C. the expertise to handle complex defective prescription drug cases. The firm has represented clients in wide range of product liability cases in the last three decades and has worked with nationally recognized co-counsel to reach successful settlements for clients and they can help you too. Visit: www.migliorelaw.com/
Available in generic form since 1982, Reglan is also sold in the U.S. under the brand name Maxolon and other names. Despite the many studies showing that Reglan was associated with tardive dyskinesia, the drug's manufacturers did place a warning on the label until 2004, and did not add the Black Box warning until February 2009.
Further investigation into Reglan determined that patients, including infants and children, and the elderly, faced significant risk of developing tardive dyskinesia. The risk is especially associated with those who have been on the drug for a long time, although symptoms have surfaced in patients after short-term use. Even after patients stop taking Reglan, symptoms of tardive dyskinesia occur.
For more than 30 years, doctors have been prescribing the drug Reglan to treat acid reflux, nausea, vomiting (in cancer patients) and gastroparesis, leaving countless victims to suffer from the frightening effects of tardive dykinesia.
A neurological disorder, tardive dyskinesia causes uncontrollable, repetitive movements of the body, such as grimacing, lip smacking, eye blinking or rapid leg and arm movements. The symptoms are rarely reversible and there is no known treatment.
If you or someone you care about has taken Reglan and developed symptoms of tardive dyskinesia, legal help is available. Call the Long Island, NY law firm of Rudolph F.X. Migliore, P.C. at (631) 543-3663 for a no cost, no obligation case evaluation.
While the harm the drug caused cannot be undone, attorney Rudolph Migliore and his team will fight to recover compensation for damages and hold liable parties responsible.
Extensive product liability experience gives the Long Island law firm of Rudolph F.X. Migliore, P. C. the expertise to handle complex defective prescription drug cases. The firm has represented clients in wide range of product liability cases in the last three decades and has worked with nationally recognized co-counsel to reach successful settlements for clients and they can help you too. Visit: www.migliorelaw.com/
Subscribe to:
Posts (Atom)